title: Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
authors.forename: Matthias
authors.initials: M
authors.lastname: Moehrle
authors.forename: Helmut
authors.initials: H
authors.lastname: Breuninger
authors.forename: Wilfried
authors.initials: W
authors.lastname: Schippert
authors.forename: Hans-Martin
authors.initials: HM
authors.lastname: Häfner
mesh_terms: D000634:Aminoquinolines / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D006801:Humans; D000077271:Imiquimod; D015580:Mohs Surgery; D020360:Neoadjuvant Therapy; D009669:Nose Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*
chemical_list: D000634:Aminoquinolines; D000970:Antineoplastic Agents; D000077271:Imiquimod